ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
69,295.68
-0.05%
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs Yen
156.70
0.01%
Brent Oil
79.395
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Generation Bio Company (GBIO)

  7. Generation Bio Company (GBIO) ニュース

GBIO

Generation Bio (GBIO)

Generation Bio Company
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:GBIO
日付受信時刻ニュースソース見出しコード企業名
2024/06/0805 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/05/1405 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
2024/05/1405 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/05/1405 : 05GlobeNewswire Inc.Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
2024/05/0919 : 59GlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
2024/04/2306 : 31GlobeNewswire Inc.Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
2024/04/0219 : 59GlobeNewswire Inc.Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
2024/03/0706 : 38Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GBIOGeneration Bio Company
2024/03/0706 : 30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GBIOGeneration Bio Company
2024/03/0706 : 25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/03/0706 : 20GlobeNewswire Inc.Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:GBIOGeneration Bio Company
2024/02/2720 : 59GlobeNewswire Inc.Generation Bio to Present at the 2024 TD Cowen Health Care ConferenceNASDAQ:GBIOGeneration Bio Company
2024/02/0306 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/02/0106 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/02/0106 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/1807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/1807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/1807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/1807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/1807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/1807 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/0821 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
2024/01/0406 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/0406 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/0406 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/0406 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/0406 : 35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2024/01/0406 : 05GlobeNewswire Inc.Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
2023/12/1206 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
2023/12/0706 : 30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
 Showing the most relevant articles for your search:NASDAQ:GBIO

最近閲覧した銘柄

NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
USOTC
ADDYY
Adidas (QX)
USI
USTECH100
US Tech 100
AMEX
SPY
SPDR S&P 500
NYSE
AXP
American Express
NASDAQ
GOOGL
Alphabet
FX
USDEUR
US Dollar vs Euro
NYSE
CVX
Chevron
NYSE
MRK
Merck
CCOM
US100
US Tech 100
NYSE
VZ
Verizon Communications
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有